GTBPVSREFR• 3 Months (Normalized)
GTBP vs REFR (GT Biopharma Inc. vs Research Frontiers Incorporated)
Showing Closing Date Range from Jul 3 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1303.06%
GT Biopharma Inc.
Normalized Baseline0.00%
REFR Performance $0.74
+%
Research Frontiers Incorporated
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1303.06 pts
GTBP outperforming by 1303.06 percentage points
GTBPREFR
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP REFR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | GTBP Price | GTBP Gain (%) | REFR Price | REFR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1303.06% | $- | - | |
| Sep 28, 2026 | $6.80 | +1287.76% | $- | - | |
| Sep 25, 2026 | $6.89 | +1306.12% | $- | - | |
| Sep 24, 2026 | $6.83 | +1293.88% | $0.74 | +37.17% | +1256.71% |
| Sep 23, 2026 | $7.10 | +1348.98% | $0.71 | +31.48% | +1317.50% |
| Sep 22, 2026 | $- | $0.78 | +44.44% | - | |
| Sep 21, 2026 | $7.18 | +1365.31% | $0.76 | +40.74% | +1324.57% |
| Sep 18, 2026 | $7.16 | +1361.22% | $0.65 | +20.37% | +1340.85% |
| Sep 17, 2026 | $7.49 | +1428.57% | $0.39 | -27.78% | +1456.35% |
| Sep 16, 2026 | $7.81 | +1493.88% | $0.38 | -29.63% | +1523.51% |
| Sep 15, 2026 | $9.00 | +1736.73% | $0.36 | -33.33% | +1770.06% |
| Sep 14, 2026 | $11.63 | +2273.47% | $0.38 | -29.63% | +2303.10% |
| Sep 11, 2026 | $8.61 | +1657.14% | $0.39 | -27.78% | +1684.92% |
| Sep 10, 2026 | $6.18 | +1161.22% | $0.39 | -27.78% | +1189.00% |
| Sep 09, 2026 | $5.98 | +1120.41% | $0.39 | -27.78% | +1148.19% |
Page 1 of 5